Literature DB >> 14249432

ABSORPTION, METABOLISM, AND EXCRETION OF OXAZEPAM AND ITS SUCCINATE HALF-ESTER.

S S WALKENSTEIN, R WISER, C H GUDMUNDSEN, H B KIMMEL, R A CORRADINO.   

Abstract

Entities:  

Keywords:  ANTIDEPRESSIVE AGENTS; BLOOD; CARBON ISOTOPES; CLINICAL RESEARCH; DOGS; EXCRETION; EXPERIMENTAL LAB STUDY; FECES; INTESTINAL ABSORPTION; METABOLISM; OXAZEPAM; RATS; SUCCINATES; SWINE; URINE

Mesh：

Substances：

Year:  1964        PMID： 14249432     DOI： 10.1002/jps.2600531010

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  5 in total

1.  Physiological modeling of drug and metabolite: disposition of oxazepam and oxazepam glucuronides in the recirculating perfused mouse liver preparation.

Authors:  M V St-Pierre; D van den Berg; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

2.  Identification of oxaxepam and lorazepam glucuronides by chemical ionization mass spectrometry.

Authors:  T T Chang; C F Kuhlman; R T Schillings; S F Sisenwine; C O Tio; H W Ruelius
Journal:  Experientia       Date:  1973-06-15

3.  Studies on the absorption, distribution and elimination of 6-o-chlorophenyl-2,4-dihydro-2(N-methyl-piperazin-1-yl)-methylene-8-nitro-1H-imidazo[1,2-a] [1,4]benzodiazepin-1-one methanesulphonate in the male rat and rabbit.

Authors:  G W James; P D Kennewell; J B Taylor; D K Luscombe; P J Nicholls
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

4.  Structural parameters in the microsomal hydrolysis of 3-acyloxy-1, 4-benzodiazepines and the multiplicity of the esterases involved.

Authors:  G Maksay; Z Tegyey; E Simon-Trompler; L Otvös
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

Review 5.  The Neonatal and Juvenile Pig in Pediatric Drug Discovery and Development.

Authors:  Miriam Ayuso; Laura Buyssens; Marina Stroe; Allan Valenzuela; Karel Allegaert; Anne Smits; Pieter Annaert; Antonius Mulder; Sebastien Carpentier; Chris Van Ginneken; Steven Van Cruchten
Journal:  Pharmaceutics       Date:  2020-12-30       Impact factor: 6.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.